FRANCHETTI, Palmarisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.072
EU - Europa 1.913
AS - Asia 1.224
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 8
OC - Oceania 4
AF - Africa 2
Totale 9.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.838
CN - Cina 932
IT - Italia 345
DE - Germania 335
SE - Svezia 275
UA - Ucraina 240
CA - Canada 233
GB - Regno Unito 204
FR - Francia 138
PL - Polonia 134
SG - Singapore 129
FI - Finlandia 111
TR - Turchia 80
IE - Irlanda 50
CZ - Repubblica Ceca 29
EU - Europa 25
IR - Iran 23
BE - Belgio 18
IN - India 16
VN - Vietnam 15
RS - Serbia 9
JP - Giappone 7
RO - Romania 6
HK - Hong Kong 5
CL - Cile 3
KR - Corea 3
NL - Olanda 3
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
AR - Argentina 2
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
IL - Israele 2
KH - Cambogia 2
PK - Pakistan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.248
Salva come PNG Salva come JPEG
Città #
Jacksonville 617
Woodbridge 591
Fairfield 586
Chandler 438
Houston 411
Ashburn 398
Ann Arbor 388
Wilmington 252
Seattle 250
Boardman 239
Nanjing 215
Cambridge 200
Toronto 156
Kraków 131
San Mateo 111
Düsseldorf 102
Singapore 80
Dearborn 78
Lawrence 77
Princeton 77
Columbus 76
Istanbul 70
Lachine 70
Nanchang 70
Beijing 69
Ogden 60
Dublin 48
Tianjin 44
Shenyang 43
New York 42
Kunming 37
Helsinki 35
Hebei 33
Jiaxing 32
Jinan 32
London 31
Washington 31
Guangzhou 30
Leawood 30
Venezia 30
Milan 27
Shanghai 26
Redwood City 24
Los Angeles 22
San Diego 20
Falls Church 19
Brussels 18
Changsha 18
Camerino 17
Hangzhou 17
Ardabil 15
Brno 15
Dong Ket 15
Hefei 15
Wuhan 15
Zhengzhou 15
Acquaviva 13
Auburn Hills 13
Augusta 12
Chicago 12
Verona 12
Ningbo 11
Venice 11
Changchun 10
Jinhua 10
Lanzhou 10
Monmouth Junction 9
Norwalk 9
Olomouc 9
Philadelphia 9
Taizhou 8
Yiwu 8
Kocaeli 7
Mumbai 7
Belgrade 6
Fuzhou 6
Munich 6
Orange 6
Shenzhen 6
Andover 5
Bremen 5
Nürnberg 5
Perugia 5
Prague 5
Strasbourg 5
Zanjan 5
Ardea 4
Chengdu 4
Edinburgh 4
Fayetteville 4
Indiana 4
San Francisco 4
Simi Valley 4
Timisoara 4
Auckland 3
Berlin 3
Bologna 3
Chongqing 3
Clifton 3
Council Bluffs 3
Totale 6.903
Salva come PNG Salva come JPEG
Nome #
Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors 180
8-Aza analogues of deaza purine nucleosides. Synthesis and biological evaluation of 8-aza-1-deazaadenosine and 2'-deoxy-8-aza-1-deazaadenosine 179
Synthesis and antiviral activity of 8-aza analogs of chiral [2-(Phosphono-methoxy)propyl]guanines. 173
Targeting Nucleotide Dimers Containing Antiviral Nucleosides 165
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. 165
8-Azaxanthine derivatives as antagonists of adenosine receptors. 162
Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents 159
Synthesis and Biological Evaluation of NAD Analogs as Human Pyridine Nucleotide Adenylyltransferase Inhibitors 159
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 159
8-Aza-1-deaza purine nucleosides as antiviral agents. 154
Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade 154
Purine and pyrimidine nucleoside analogs of 3'-C-methyladenosine as antitumor agents 154
Isosteric Analogues of Nicotinamide Adenine Dinucleotide Derived from Furanfurin, Thiophenfurin, and Selenophenfurin as Mammalian Inosine Monophosphate dehydrogenase (Type I and II) Inhibitors 148
A new facile synthesis and antiviral activity of oxazofurin 146
Stereoselective synthesis of nicotinamide β-riboside and nucleoside analogs 146
Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2',3'-didehydro-2',3'-dideoxy-3-deazaadenosine, 2',3'-dideoxy-3-deazaadenosine and some 2',3'-dideoxy-3-deazaadenosine 5'-dialkyl phosphates 145
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 145
Synthesis and IMP dehydrogenase (type I and type II) inhibitory activity of isosteric NAD analogs derived from thiophenfurin and furanfurin 143
Pharmacokinetic and antiretroviral activity in mice of oral [P1,P2-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 143
Synthesis and antitumor activity of a heterodinucleotide of BVDU and Gemcitabine 141
Acyclic nucleotides related to clitocine: synthesis and anti-HIV activity 141
Synthesis, antitumor activity and crystallographic studies of analogues of tiazofurin 140
Dinucleoside polyphosphate NAD analogs as potential NMN adenylyltransferase inhibitors. Synthesis and biological evaluation 139
Preparation of purine and 8-azapurine derivatives for treatment of acquired immune deficiency syndrome. 139
The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells 138
Ribose-modified mizoribine analogues: synthesis and biological evaluation 135
Synthesis and anti-HIV activity of isonucleosides and acyclic nucleotides related to clitocine 135
5’-Carbamoyl Derivatives of 2'-C-Methyl-purine Nucleosides as Selective A1 Adenosine Receptor Agonists: Affinity, Efficacy and Selectivity for A1 Receptor from Different Species. 134
Synthesis and cytotoxic activity of selenophenfurin, a new inhibitor of IMP dehydrogenase 134
2’-C-Methyl derivatives of tecadenoson and 2-chloro-tecadenoson with increased selectivity for human A1 adenosine receptor 132
Structure-activity relationships of tiazofurin analogs: synthesis and computational studies of 4'-thio derivatives of thiophenfurin and furanfurin 131
Synthesis and antiviral evaluation of 1-deaza-8-aza- and 3-deaza-8-aza-purine nucleosides 131
A new tiazofurin pronucleotide: synthesis and biological evaluation of CycloSaligenyl-tiazofurin monophosphate 129
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 126
A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus 125
ATP-mimetics derived from 2 '(3 ')-C-methyladenosine as human P2Y2 agonists 124
Synthesis, structure, and antiproliferative activity of selenophenfurin, an IMP dehydrogenase inhibitor analogue of selenazofurin. 124
ADP- and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 receptor ligands 124
Ribose-modified nucleosides as ligands for adenosine receptors: synthesis, conformational analysis, and biological evaluation of 1'-C-methyl adenosine analogues 120
Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus 120
Selective inhibition of nicotinamide adenine kinases (NADKs) by compact NAD mimics 119
C-Glycosyl bond conformation in oxazofurin: crystallographic and computational studies of the oxazole analogue of tiazofurin. 118
Synthesis and evaluation of the anti-HIV activity of aza and deaza analogues of IsoddA and their phosphates as prodrugs. 118
8-Aza derivatives of 3-deazapurine nucleosides. Synthesis and in vitro evaluation of antiviral and antitumor activity 115
Furanfurin and Thiophenfurin: Two Novel Tiazofurin Analogues. Synthesis, Structure, Antitumor Activity and Interactions with IMP Dehydrogenase 114
Tiazofurin analogs as selective agonists of A1 adenosine receptors 112
Synthesis of 3-deazaclitocine [2-amino-3-nitro-4-(beta-D-ribofuranosylamino)pyridine] as cytotoxic agent 112
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 112
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF NOVEL HYDRAZONE DERIVATIVES 112
8-Aza-analogues of PMEA and PMEG: synthesis and in vitro anti-HIV activity. 110
C-Nucleoside Analogs of Tiazofurin and Selenazofurin as Inosine 5'-Monophosphate Deydrogenase Inhibitors 108
5’-CHLORO-5’-DEOXY-N6-SUBSTITUTED ADENOSINE DERIVATIVES: SYNTHESIS, ADENOSINE RECEPTOR AFFINITY AND ANTINOCICEPTIVE ACTIVITY 106
Synthesis, Conformational Analysis, and Biological Activity of C-Thioribonucleosides Related to Tiazofurin 105
Labelling of A1 and A3 adenosine receptors with the new selective A1 agonist 2'-Me-CCPA 104
Decomposition pathways and in vitro HIV inhibitory effects of isoddA pronucleotides: towards a rational approach of intracellular delivery of nucleoside 5'-monophosphates 102
Novel hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells 101
Inhibition of human immunodeficency virus replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine. 100
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N-6-substituted 3'-C-methyladenosine derivatives 97
Early evaluation of a new 2,2'-bipyridyl derivative with potential inhibitory activity on the ribocleotide reductase enzyme 97
2'-C-Methyl-2-chloro-N6-cyclopentyladenosine, a potent and highly selective A1 adenosine receptor agonist, has antinociceptive activity and modulates RVM on-and-off cell activities 96
Structure-affinity relathionships of 5'-carbamoyl- and 5'-thionocarbamoyl derivatives of the A1 selective adenosine receptor agonist 2'-MeCCPA as partial A1 agonists 96
2'-C-Methyl analogs of selective adenosine receptors agonists: synthesis and binding studies 95
Affinity and selectivity of tecadenoson, 2-chloro-tecadenoson and 2’-C-methyl analogues at bovine and pig A1 adenosine receptor 94
HISTONE DEACETYLASE (HDAC) INHIBITION MODULATES INTRACELLULAR DEOXYNUCLEOTIDES (DNTP) POOLS AND POTENTIATES THE ANTITUMOR EFFECTS OF THE RIBONUCLEOTIDE REDUCTASE (RR) INHIBITOR 3’- METHYL-ADENOSINE (3’-ME-ADO) IN PROMYELOCITIC LEUKAEMIA CELL LINES. 92
Red Blood cells as drug delivery system for antiviral nucleotide analogues 90
3’-C-Methyl-ribosyl nucleosides as cytotoxic compounds 89
C-Nucleoside Analogues of Furanfurin as Ligands to A(1) Adenosine Receptors 89
EFFECTS OF METAL(III) COORDINATION ON BIOLOGICAL ACTIVITY OF 2,2'-BIPYRIDYL-6-CARBOTHIOAMIDE (BPYTA), A POTENT R2 RIBONUCLEOTIDE REDUCTASE INHIBITOR 88
Selective targeting to macrophages of a new homodinucleotide active aginst human immunodeficiency virus and herpes simplex virus 87
ADP-, and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 ligands 87
A new C-Nucleoside Analogue of Tiazofurin: Synthesis and Biological Evaluation of 2-beta-D-Ribofuranosylimidazole-4-carboxamide (Imidazofurin) 85
IMP Dehydrogenase as a target of antitumor and antiviral chemotherapy 84
Effects of the selective adenosine A1 receptor agonist 5 '-chloro-5 '-deoxy-N6-(2-endo-norbornyl) adenosine on nociception in mice 78
New N6-substituted adenosine and 3’-C-methyl-adenosine derivatives as antitumor agents 78
Effects of 5'-chloro-5'-deoxy-N6-(±)-endo-norbornyl-adenosine, a potent and highly selective A1 adenosine receptor agonist, on neuropathic pain-induced behavioural and morphological changes in spinal microglia 78
Synthesis and in vivo antiviral activity of 8-aza-analogues of potent antiviral agents 9-[2-phosphonomethoxy)ethyl]adenine (PMEA) and 9-[2-phosphonomethoxy)ethyl]guanine (PMEG) 75
Dual-target dimeric molecules with antitumor properties. Synthesis and biological activity of 3’-C-methyladenosine-valproates 74
Totale 9.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020971 0 0 0 0 94 176 161 181 119 108 33 99
2020/20211.231 32 101 55 98 67 76 149 12 109 29 337 166
2021/2022878 72 209 10 63 46 57 18 58 65 87 91 102
2022/20231.134 130 26 61 162 117 163 3 101 214 49 76 32
2023/2024820 119 40 63 17 46 120 24 26 82 36 10 237
2024/2025504 98 59 215 89 43 0 0 0 0 0 0 0
Totale 9.358